Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heartbeam Inc (NQ: BEAT )

1.450 -0.020 (-1.36%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,036
Open 1.470
Bid (Size) 1.410 (9)
Ask (Size) 1.490 (1)
Prev. Close 1.470
Today's Range 1.410 - 1.500
52wk Range 1.110 - 6.000
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q3 2023 Financial Report, Operational Update
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
HeartBeam Reports Third Quarter 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire

Performance

YTD
-68.48%
-68.48%
1 Month
+9.85%
+9.85%
3 Month
-33.79%
-33.79%
6 Month
-46.30%
-46.30%
1 Year
-69.92%
-69.92%

More News

Read More
Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition!
Via IssueWire
Topics Religion
Exposures Religion
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Scientific Advisory Board as It Advances Product Development, Clinical and Commercial Efforts
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HeartBeam Announces Expansion of Its Scientific Advisory Board
From HeartBeam, Inc.
Via Business Wire
HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Third Quarter 2023 Results Conference Call
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Leaders to New Senior Management Positions
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team
From HeartBeam, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2023 Financial Report, Corporate Update
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
HeartBeam Reports Second Quarter 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces First Peer-Reviewed Publication Based on Its VECG Technology
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Deborah Castillo to Lead Regulatory Strategy and Execution
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q2 2023 Results Call, Webcast
Via Investor Brand Network
HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Physician, Researcher to Board of Directors
Via Investor Brand Network
HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Wealth of Expertise to Its Board with Appointments of Ken Nelson and Mark Strome
Via Investor Brand Network
HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors
From HeartBeam, Inc.
Via Business Wire
Strategic Alliance with Samsung and Collaboration with Dept. of Veterans Affairs to Advance Use of Unique 3-D Telehealth Technology for Heart Attack Detection and Quicker Response: BEAT
Via Get News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.